View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.
Dr. Yihong Qiu is currently a Senior Research Fellow, Drug Products, Operations Science and Technology, AbbVie. His in-depth knowledge and extensive experience encompass various phases of product development, including preformulation, drug delivery technology, product/process design, biopharmaceutics/pharmacokinetics, formulation/process development, scale-up and optimization, manufacturing trouble-shooting, intellectual property and regulatory registration for NCE’s, line-extension and marketed products. During his 25-year tenure with Abbott/AbbVie, his work has resulted in successful commercial IR and MR products, patented drug delivery technologies, IVIVC’s and biowaivers approved by global regulatory agencies. He also plays a key role in the product life cycle management, IP strategy, scientific and regulatory assessment of business opportunities. Dr. Qiu’s research interests include modified-release delivery, enhancing dissolution and oral bioavailability, IVIVC, drug delivery technology and science-based regulations. He is an elected fellow of the American Association of Pharmaceutical Scientists (AAPS), a member of USP Expert Committee (2010-15) and a review committee member of Chang Jiang Scholars Program (2014-15). He has more than 60 publications in journals and books, over 30 patents granted or pending, and numerous invited presentations at conferences, universities and regulatory agencies. Dr. Qiu received BS in Pharmacy, MS. in Pharmaceutics from China Pharmaceutical University, and Ph.D. in Pharmaceutics from The University of Iowa.